Carecore At Lima Llc Medicare and Medicaid Location: 599 South Shawnee Street, Lima, Ohio 45804 Ratings: Phone: (419) 227-2154 |
Lima Manor Medicare and Medicaid Location: 750 Brower Road, Lima, Ohio 45801 Ratings: Phone: (419) 227-2611 |
Shawnee Manor Medicare and Medicaid Location: 2535 Fort Amanda Road, Lima, Ohio 45804 Ratings: Phone: (419) 999-2055 |
Lost Creek Health Care And Rehabilitation Center Medicare and Medicaid Location: 804 South Mumaugh Road, Lima, Ohio 45804 Ratings: Phone: (419) 225-9040 |
Liberty Retirement Community Of Lima Inc Medicare and Medicaid Location: 2440 Baton Rouge Avenue, Lima, Ohio 45805 Ratings: Phone: (419) 331-2273 |
Springview Manor Medicare and Medicaid Location: 883 West Spring Street, Lima, Ohio 45805 Ratings: Phone: (419) 227-3661 |
Lima Convalescent Home Medicare and Medicaid Location: 1650 Allentown Road, Lima, Ohio 45805 Ratings: Phone: (419) 224-9741 |
Springs Of Lima The Medicare and Medicaid Location: 370 North Eastown Road, Lima, Ohio 45807 Ratings: Phone: (419) 221-6051 |
News Archive
Biopharmaceuticals, medium- and high-molecular weight biologically active macromolecules, are not easily absorbed by the small intestine, the main organ responsible for gastrointestinal absorption, resulting in a bottleneck for oral administration type biopharmaceutical development.
Nonin Medical, Inc., a global leader in noninvasive medical monitoring, today announced that the company's Nonin Labs division will be demonstrating the world's smallest regional oximetry system and the first Apple iPhone/iPod-enabled regional oximeter at Hall 11, Stand D42, at MEDICA, Nov. 20-24, at the Messe in Dusseldorf, Germany. The technologies are investigational and do not have a time-table for commercialization.
Symphogen A/S today announced that it has initiated a Phase 1/2 human clinical trial in the US to evaluate the safety, tolerability and efficacy of its drug candidate Sym004 for the treatment of advanced solid tumors. Sym004 is composed of two anti-epidermal growth factor receptor monoclonal antibodies targeting different nonoverlapping EGFR epitopes.
Tengion, Inc., a leader in regenerative medicine, announced today it has added The Johns Hopkins Hospital in Baltimore, Maryland as a second clinical trial site for its Phase I clinical trial of the Company's lead product candidate, the Tengion Neo-Urinary Conduitâ„¢, in bladder cancer patients requiring bladder removal.
› Verified 9 days ago